Finnerty Molly, Neese-Todd Sheree, Bilder Scott, Olfson Mark, Crystal Stephen
Dr. Finnerty is with the Department of Child and Adolescent Psychiatry, New York University Langone Medical Center, and with the Bureau of Evidence-Based Services and Implementation Science, New York State Office of Mental Health, New York City (e-mail:
Psychiatr Serv. 2014 Nov 1;65(11):1297-9. doi: 10.1176/appi.ps.201400343.
States face new federal requirements to monitor psychotropic prescribing practices for children and adults enrolled in Medicaid. Effective use of quality measurement and quality improvement strategies hold the promise of improved outcomes for public mental health systems. The Medicaid/Mental Health Network for Evidence-Based Treatment (MEDNET), funded by the Agency for Healthcare Research and Quality, is a multistate Medicaid quality collaborative with the Rutgers University Center for Health Services Research on Pharmacotherapy, Chronic Disease Management, and Outcomes. This column describes the development, infrastructure, challenges, and early evidence of success of this public-academic partnership, the first multistate Medicaid quality improvement collaborative to focus on psychotropic medications.
各州面临新的联邦要求,需对参加医疗补助计划的儿童和成人的精神药物处方行为进行监测。有效利用质量衡量和质量改进策略有望改善公共心理健康系统的成效。由医疗保健研究与质量局资助的医疗补助计划/循证治疗心理健康网络(MEDNET)是一个多州医疗补助计划质量合作项目,与罗格斯大学卫生服务研究中心合作开展药物治疗、慢性病管理及成效方面的研究。本专栏介绍了这一公共-学术伙伴关系的发展、基础设施、挑战及早期成功证据,这是首个专注于精神药物的多州医疗补助计划质量改进合作项目。